DE2115926C3 - 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel - Google Patents

1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel

Info

Publication number
DE2115926C3
DE2115926C3 DE2115926A DE2115926A DE2115926C3 DE 2115926 C3 DE2115926 C3 DE 2115926C3 DE 2115926 A DE2115926 A DE 2115926A DE 2115926 A DE2115926 A DE 2115926A DE 2115926 C3 DE2115926 C3 DE 2115926C3
Authority
DE
Germany
Prior art keywords
hydroxy
preparation
dimethylaminosulfamidophenyi
compositions containing
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2115926A
Other languages
German (de)
English (en)
Other versions
DE2115926B2 (de
DE2115926A1 (de
Inventor
Anton Dr. Mentrup
Ernst-Otto Dr. Renth
Kurt Dr. Schromm
Werner Dr. 6531 Muenster Traunecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C.H. Boehringer Sohn AG and Co KG
Original Assignee
C.H. Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.H. Boehringer Sohn AG and Co KG filed Critical C.H. Boehringer Sohn AG and Co KG
Priority to DE2115926A priority Critical patent/DE2115926C3/de
Priority to AR244859A priority patent/AR204905A1/es
Priority to NO1061/72A priority patent/NO135247C/no
Priority to DK154772AA priority patent/DK140836B/da
Priority to ES401332A priority patent/ES401332A1/es
Priority to IL39110A priority patent/IL39110A/xx
Priority to PH13398A priority patent/PH14121A/en
Priority to CH1056976A priority patent/CH590219A5/xx
Priority to CH1390375A priority patent/CH580068A5/xx
Priority to CH1390275A priority patent/CH572905A5/xx
Priority to ZA722177A priority patent/ZA722177B/xx
Priority to NLAANVRAGE7204316,A priority patent/NL170850C/xx
Priority to CH1647576A priority patent/CH587237A5/xx
Priority to FI915/72A priority patent/FI58325C/fi
Priority to CH482372A priority patent/CH587236A5/xx
Priority to SE7204239A priority patent/SE393106B/xx
Priority to AU40592/72A priority patent/AU470838B2/en
Priority to IE415/72A priority patent/IE36240B1/xx
Priority to GB1515672A priority patent/GB1381184A/en
Priority to CH1390475A priority patent/CH580069A5/xx
Priority to AT915174*1A priority patent/ATA915174A/de
Priority to JP3180472A priority patent/JPS5735193B1/ja
Priority to AT00895/74A priority patent/AT320613B/de
Priority to AT89474*A priority patent/AT321888B/de
Priority to AT915174*7A priority patent/AT327174B/de
Priority to AT915074*7A priority patent/AT327173B/de
Priority to BE781542A priority patent/BE781542A/xx
Priority to AT284472A priority patent/AT326628B/de
Priority to FR7211614A priority patent/FR2132372B1/fr
Publication of DE2115926A1 publication Critical patent/DE2115926A1/de
Priority to AR244858A priority patent/AR200002A1/es
Priority to AR244860A priority patent/AR200116A1/es
Priority to ES419935A priority patent/ES419935A1/es
Priority to ES419934A priority patent/ES419934A1/es
Priority to ES419936A priority patent/ES419936A1/es
Priority to AR251170A priority patent/AR210055A1/es
Priority to AR251169A priority patent/AR199809A1/es
Priority to AR251171A priority patent/AR209268A1/es
Priority to US05/453,438 priority patent/US4038314A/en
Priority to AT89674*A priority patent/AT321889B/de
Publication of DE2115926B2 publication Critical patent/DE2115926B2/de
Application granted granted Critical
Publication of DE2115926C3 publication Critical patent/DE2115926C3/de
Priority to JP56078170A priority patent/JPS5929191B2/ja
Priority to JP56078169A priority patent/JPS5929190B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE2115926A 1971-04-01 1971-04-01 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel Expired DE2115926C3 (de)

Priority Applications (41)

Application Number Priority Date Filing Date Title
DE2115926A DE2115926C3 (de) 1971-04-01 1971-04-01 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
AR244859A AR204905A1 (es) 1971-04-01 1972-01-01 Procedimiento para la preparacion de 1-(4-hidroxi-3-dimetilamino-sulfonamido-fenil)-2-aminoetano
NO1061/72A NO135247C (enExample) 1971-04-01 1972-03-28
ES401332A ES401332A1 (es) 1971-04-01 1972-03-29 Procedimiento para la preparacion de sulfamidas.
IL39110A IL39110A (en) 1971-04-01 1972-03-29 Sulphamides,their preparation and pharmaceutical compositions containing them
PH13398A PH14121A (en) 1971-04-01 1972-03-29 1-(4'-hydroxy-3'-aminosulfonamido-phenyl)-2-amino-ethanes and salts
DK154772AA DK140836B (da) 1971-04-01 1972-03-29 Analogifremgangsmåde til fremstilling af 1-(4-hydroxy-3-dimethylaminosulfonamidophenyl)-1-hydroxy-2-aminoethanderivater i form af racemater eller optiske antipoder, eller syreadditionssalte deraf.
CH1390375A CH580068A5 (enExample) 1971-04-01 1972-03-30
CH1056976A CH590219A5 (enExample) 1971-04-01 1972-03-30
ZA722177A ZA722177B (en) 1971-04-01 1972-03-30 Improvements relating to sulphamides
NLAANVRAGE7204316,A NL170850C (nl) 1971-04-01 1972-03-30 Werkwijze voor het bereiden of vervaardigen van een geneesmiddel met perifere vaten verwijdende, bloeddruk verlagende, hart stimulerende en broncholytische werking en werkwijze voor het bereiden van daarvoor geschikte fenylaminoethaanderivaten.
CH1647576A CH587237A5 (enExample) 1971-04-01 1972-03-30
FI915/72A FI58325C (fi) 1971-04-01 1972-03-30 Foerfarande foer framstaellning av farmakologiskt vaerdefulla sulfamider
CH482372A CH587236A5 (enExample) 1971-04-01 1972-03-30
SE7204239A SE393106B (sv) 1971-04-01 1972-03-30 Forfarande for framstellning av sulfonamider med kerldilaterande verken
AU40592/72A AU470838B2 (en) 1971-04-01 1972-03-30 Sulphamides
IE415/72A IE36240B1 (en) 1971-04-01 1972-03-30 1-hydroxy-1-((4'-hydroxy-3'aminosulfonamido)-phenyl)-2-amino-ethanes and salts [us4038314a]
GB1515672A GB1381184A (en) 1971-04-01 1972-03-30 Sulphamides
CH1390475A CH580069A5 (enExample) 1971-04-01 1972-03-30
CH1390275A CH572905A5 (en) 1971-04-01 1972-03-30 Sulphamido-aralkylamine cpds - with vasodilatory, cardiac-stimulant, blood-pressure, and broncholytic activity
AT915174*1A ATA915174A (de) 1971-04-01 1972-03-31 Verfahren zur herstellung von neuen sulfamiden und deren saureadditionssalzen
JP3180472A JPS5735193B1 (enExample) 1971-04-01 1972-03-31
AT00895/74A AT320613B (de) 1971-04-01 1972-03-31 Vzh von neuen sulfamiden
AT89474*A AT321888B (de) 1971-04-01 1972-03-31 Verfahren zur herstellung von neuen sulfamidensowie deren saeureadditionssalzen
AT915174*7A AT327174B (de) 1971-04-01 1972-03-31 Verfahren zur herstellung von neuen sulfamiden und deren saureadditionssalzen
AT915074*7A AT327173B (de) 1971-04-01 1972-03-31 Verfahren zur herstellung von neuen sulfamiden und deren saureadditionssalzen
BE781542A BE781542A (fr) 1971-04-01 1972-03-31 Sulfamides
AT284472A AT326628B (de) 1971-04-01 1972-03-31 Verfahren zur herstellung von neuen sulfamiden und deren säureadditionssalzen
FR7211614A FR2132372B1 (enExample) 1971-04-01 1972-03-31
AR244858A AR200002A1 (es) 1971-04-01 1972-10-27 Procedimiento para la preparacion de sulfonamidas
AR244860A AR200116A1 (es) 1971-04-01 1972-10-27 Procedimiento para la preparacion de sulfonamidas
ES419934A ES419934A1 (es) 1971-04-01 1973-10-25 Procedimiento para la preparacion de sulfamidas.
ES419935A ES419935A1 (es) 1971-04-01 1973-10-25 Procedimiento para la preparacion de sulfamidas.
ES419936A ES419936A1 (es) 1971-04-01 1973-10-25 Procedimiento para la preparacion de sulfamidas.
AR251171A AR209268A1 (es) 1971-04-01 1973-11-26 Procedimiento para la preparacion de 1-(4-hidroxi-2- aminosulfonamidofenil)-2-aminoetano
AR251170A AR210055A1 (es) 1971-04-01 1973-11-26 Procedimiento para la preparacion de derivados sustituidos del 1-(4-hidroxi-3-aminosulfonamidofenil)-2-aminoetano
AR251169A AR199809A1 (es) 1971-04-01 1973-11-26 Procedimiento para la preparacion de sulfonamidas
US05/453,438 US4038314A (en) 1971-04-01 1974-03-21 1-Hydroxy-1-[(4'-hydroxy-3'aminosulfonamido)-phenyl]-2-amino-ethanes and salts
AT89674*A AT321889B (de) 1971-04-01 1974-03-31 Verfahren zur herstellung von neuen sulfamidensowie deren saeureadditionssalzen
JP56078170A JPS5929191B2 (ja) 1971-04-01 1981-05-25 スルホンアミド誘導体
JP56078169A JPS5929190B2 (ja) 1971-04-01 1981-05-25 スルホンアミド化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2115926A DE2115926C3 (de) 1971-04-01 1971-04-01 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel

Publications (3)

Publication Number Publication Date
DE2115926A1 DE2115926A1 (de) 1972-10-12
DE2115926B2 DE2115926B2 (de) 1977-09-15
DE2115926C3 true DE2115926C3 (de) 1978-05-03

Family

ID=5803592

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2115926A Expired DE2115926C3 (de) 1971-04-01 1971-04-01 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel

Country Status (20)

Country Link
US (1) US4038314A (enExample)
JP (3) JPS5735193B1 (enExample)
AR (6) AR204905A1 (enExample)
AT (7) AT321888B (enExample)
AU (1) AU470838B2 (enExample)
BE (1) BE781542A (enExample)
CH (6) CH572905A5 (enExample)
DE (1) DE2115926C3 (enExample)
DK (1) DK140836B (enExample)
ES (4) ES401332A1 (enExample)
FI (1) FI58325C (enExample)
FR (1) FR2132372B1 (enExample)
GB (1) GB1381184A (enExample)
IE (1) IE36240B1 (enExample)
IL (1) IL39110A (enExample)
NL (1) NL170850C (enExample)
NO (1) NO135247C (enExample)
PH (1) PH14121A (enExample)
SE (1) SE393106B (enExample)
ZA (1) ZA722177B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3220598A1 (de) * 1982-06-01 1983-12-01 Boehringer Ingelheim KG, 6507 Ingelheim Lipolytische zusammensetzungen und mittel zur behandlung der fettsucht

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
GB8502892D0 (en) * 1985-02-05 1985-03-06 Sterwin Ag Aerosol composition
IE883400L (en) * 1987-11-13 1989-05-13 Fuisz Technologies Ltd Phenethanolamine derivatives
US20040127733A1 (en) 2002-10-31 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
DE10251170A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004021779A1 (de) 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7718822B2 (en) * 2007-08-28 2010-05-18 Sepracor Inc. Carbamate Stereoisomer
CN109535007A (zh) * 2018-11-07 2019-03-29 万华化学集团股份有限公司 一种二氨基二环己基甲烷同分异构体分离方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3804834A (en) * 1967-10-16 1974-04-16 Boehringer Sohn Ingelheim 1-(2',3',4'-trisubstituted-phenyl)-2-amino-alkanols-(1)and salts thereof
US3701808A (en) * 1967-12-21 1972-10-31 Allen & Hanburys Ltd Phenylethanolamines
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US3711545A (en) * 1971-02-23 1973-01-16 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols
BE794414A (fr) * 1972-01-25 1973-07-23 Sandoz Sa Nouveaux amino-alcools, leur preparation et leur application comme medicament

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3220598A1 (de) * 1982-06-01 1983-12-01 Boehringer Ingelheim KG, 6507 Ingelheim Lipolytische zusammensetzungen und mittel zur behandlung der fettsucht

Also Published As

Publication number Publication date
JPS5735193B1 (enExample) 1982-07-27
AR200116A1 (es) 1974-10-24
NL170850C (nl) 1983-01-03
ZA722177B (en) 1973-12-19
ATA284472A (de) 1975-03-15
ATA915074A (de) 1975-04-15
DK140836B (da) 1979-11-26
AT327173B (de) 1976-01-26
DK140836C (enExample) 1980-04-21
IE36240L (en) 1972-10-01
AR199809A1 (es) 1974-09-30
AU4059272A (en) 1973-10-04
CH572905A5 (en) 1976-02-27
CH590219A5 (enExample) 1977-07-29
DE2115926B2 (de) 1977-09-15
JPS5929190B2 (ja) 1984-07-18
AT320613B (de) 1975-02-25
ES419936A1 (es) 1976-05-01
CH587237A5 (enExample) 1977-04-29
AT327174B (de) 1976-01-26
BE781542A (fr) 1972-10-02
IL39110A (en) 1975-02-10
FI58325C (fi) 1981-01-12
NO135247B (enExample) 1976-11-29
AR200002A1 (es) 1974-10-15
JPS5718660A (en) 1982-01-30
CH580069A5 (enExample) 1976-09-30
AU470838B2 (en) 1973-10-04
NL7204316A (enExample) 1972-10-03
AT321888B (de) 1975-04-25
JPS5929191B2 (ja) 1984-07-18
FR2132372A1 (enExample) 1972-11-17
IL39110A0 (en) 1972-05-30
CH580068A5 (enExample) 1976-09-30
FR2132372B1 (enExample) 1975-06-20
US4038314A (en) 1977-07-26
FI58325B (fi) 1980-09-30
SE393106B (sv) 1977-05-02
AR209268A1 (es) 1977-04-15
NL170850B (nl) 1982-08-02
NO135247C (enExample) 1977-03-09
ES401332A1 (es) 1975-02-16
GB1381184A (en) 1975-01-22
DE2115926A1 (de) 1972-10-12
AR204905A1 (es) 1976-03-19
CH587236A5 (enExample) 1977-04-29
JPS5718662A (en) 1982-01-30
ES419934A1 (es) 1976-05-01
ATA915174A (de) 1975-04-15
PH14121A (en) 1981-02-26
AT326628B (de) 1975-12-29
AT321889B (de) 1975-04-25
AR210055A1 (es) 1977-06-30
ES419935A1 (es) 1976-05-01
IE36240B1 (en) 1976-09-15

Similar Documents

Publication Publication Date Title
DE2203373B2 (de) Neue 2- eckige klammer auf (2- alkylbenzofuran-3-yl)-methyl eckige klammer zu -delta hoch 2 -imidazoline
DE2220480A1 (de) Polymethylendiamine
DE2115926B2 (de) 1-(4-hydroxy-3-dimethylaminosulfamidophenyl)-2-aminoaethanderivate, verfahren zu ihrer herstellung und diese enthaltende mittel
DE2822307A1 (de) 3,3,3-triarylalkyl-4-phenylalkyl-4- hydroxy-piperidin und verfahren zu deren herstellung
DE2420618C2 (de) Aminoalkylanilide, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitungen, die diese Aminoalkylanilide enthalten
DE1593901B2 (de) Basisch substituierte benzofurane oder indole und verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE1720018A1 (de) N-monosubstituierte Pyrrylaminoaethanole und Verfahren zu ihrer Herstellung
DE2164636B2 (de) N-(PhenoxyalkyD- a -methylphenäthylamine, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE3009071A1 (de) 2-isopropylaminopyrimidinhydroxyderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0000784B1 (de) 4-Hydroxy-2-Benzimidazolinon-derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE1915230C3 (de) Hydroxyphenylalkylaminderivate, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
AT344151B (de) Verfahren zur herstellung von neuen naphthalinderivaten
EP0000727B1 (de) 3-(4-(1,3-Diazacycloalken-2-yl)-phenyl)-1,2-benzisothiazole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel.
DE2019344A1 (de) 4-Chlor-zimtsaeure-(4'-hydroxypiperidid)
EP0003298B1 (de) 4-Hydroxy-2-benzimidazolin-thion-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE1949987A1 (de) Neue alpha-Phenylfettsaeureverbindungen
DE2304414C3 (de) 1-[3-(trifluormethyl)phenyl]-2-[(cyanoalkyl)amino]-propane, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2237228A1 (de) Aldehydderivate
DE2114230C2 (de) Verfahren zur Herstellung von 8-Methyl-2,3,3a,4,5,6-hexahydro-1H-pyrazino(3,2,1-j,k)carbazolhydrochlorid
DE2946613C2 (de) trans-2-Amido-hexahydrobenzo[a]chinolizine und Arzneimittel, welche diese enthalten
DE2919495C2 (enExample)
WO1991001297A1 (de) 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthaline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE1620436C (de) Carboxamidoalkyl 1,3 benzoxazin 2 on derivate und Verfahren zu deren Her stellung
CH556323A (de) Verfahren zur herstellung von neuen naphthylalkylaminen.
AT333264B (de) Verfahren zur herstellung des neuen 3-(4-biphenylyl)-3-methyl-propionsaurenitrils

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee